Skip to content

Clinical study for ozonated autohemotherapy in the treatment of Hospital-acquired pneumonia

Clinical study for ozonated autohemotherapy in the treatment of Hospital-acquired pneumonia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035281
Enrollment
Unknown
Registered
2020-08-06
Start date
2020-08-01
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospital-acquired pneumonia

Interventions

control group:conventional treatment
ozonated treatment:conventional treatment and ozonated autohemotherapy

Sponsors

Beijing Rehabilitation Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) It conforms to the diagnostic criteria for hospital-acquired pneumonia in accordance with the Guidelines for Diagnosis and Treatment of Chinese Adult Hospital-acquired Pneumonia and Ventilator-associated Pneumonia (2018 edition) formulated by the Infectious Group of Respiratory Medicine Branch of Chinese Medical Association; 2) Aged from 18 to 80 years, male or female; 3) Informed consent has been signed.

Exclusion criteria

Exclusion criteria: 1) Unstable vital signs; 2) Angina pectoris, myocardial infarction or acute heart failure occurred three months before enrollment; 3) G-6PD defect (Favism); 4) Hyperthyroidism (Graves); 5) Thrombocytopenia lower than 50x109/L, severe coagulation disorders; 6) Massive blood loss, acute bleeding, anemia (<90 g/L), etc.; 7) Severe water and electrolyte disturbances; 8) Patients with hemochromatosis or treated with copper or iron agents; 9) Allergic to anticoagulant (sodium citrate); 10) Pregnancy; 11) Severe hepatic insufficiency.

Design outcomes

Primary

MeasureTime frame
Clinical Pulmonary Infection score, CPIS;Pneumonia severity index, PSI;Inflammatory response index;Arterial blood gas analysis index;Oxidative stress index;Immune cells;Respiratory function score;

Countries

China

Contacts

Public ContactXi Jianing

Beijing Rehabilitation Hospital affiliated to Capital Medical University

Xijn888@sina.com+86 18612665038

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026